SEC Form 4 · accession 0001522767-26-000157
MARIMED INC. · MRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryan Crandall
Officer — Chief Commercial Officer
Period of report
Jul 15, 2026
Accepted (ET)
Jul 17, 2026 · 4:12 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001522767
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Jul 15, 2026 | M | 32,813 | $0.00 | A | 1,135,616 | D | |
| Common stockF2 | Jul 15, 2026 | F | 11,370 | $0.0662 | D | 1,124,246 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSU)F1,F3 | — | Jul 15, 2026 | M | 32,813 | D | — | — | Common Stock, par value $.001 per share | 32,813 | 98,437 | D |
Explanation of responses
- F1RSUs convert to shares of common stock on a one-for-one basis.
- F2Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
- F3The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in three equal installments on each of October 15, 2026, January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.